Avidity Biosciences
RNA
#2645
Rank
โ‚น453.34 B
Marketcap
โ‚น3,835
Share price
2.42%
Change (1 day)
561.56%
Change (1 year)

Revenue for Avidity Biosciences (RNA)

Revenue in 2024 (TTM): โ‚น0.88 B

According to Avidity Biosciences's latest financial reports the company's current revenue (TTM) is โ‚น0.88 B. In 2023 the company made a revenue of โ‚น0.79 B an increase over the revenue in the year 2022 that were of โ‚น0.76 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avidity Biosciences from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น0.88 B10.93%
2023 โ‚น0.79 B4.27%
2022 โ‚น0.76 B9.83%
2021 โ‚น0.69 B40.25%
2020 โ‚น0.49 B200.2%
2019 โ‚น0.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น75.54 B 8,395.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.70 B 991.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น126.25 B 14,099.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น36.44 B 3,999.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.03 B 16.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.46 B 963.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.668 T 524,874.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.311 T 372,264.39%๐Ÿ‡ฌ๐Ÿ‡ง UK